metsera pfizer - Search News

Pfizer sues Metsera, Novo Nordisk

UPDATE: Novo Nordisk Seeks To Steal Metsera From Pfizer With $8.5B Offer

Novo Nordisk has submitted an unsolicited bid to buy obesity biotech Metsera out from under Pfizer, offering $6 billion upfront plus $2.5 billion in milestone-based payouts for a total of $8.5 billion. The total consideration for the deal edges out Pfizer’s offer by approximately $1.23 billion.

· 2d · on MSN

Novo Nordisk launches bidding war with Pfizer for US obesity biotech Metsera

· 2d · on MSN

Pfizer Sues to Block Novo Bid for Obesity Drugmaker Metsera

Fierce Biotech

Novo makes bombshell $6.5B counteroffer to Pfizer's acquisition of obesity biotech Metsera

For Novo, it marks the boldest move yet for recently appointed CEO Maziar Mike Doustdar. In response to a slowdown in sales growth for its blockbuster obesity drug Wegovy, Doustdar has already ...

Metsera Becomes The Prize In Obesity's Biggest Bidding War

Metsera, Inc. is at the center of a bidding war between Novo Nordisk and Pfizer, driving its stock up 20%. Learn more about ...

How Pfizer Stock Can Rebound

The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...

6don MSN

2 Unstoppable Health Care Giants to Buy Right Now for Less Than $1,000

From a more company-specific point of view, Pfizer has also agreed to buy Metsera. This will help the company deal with ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results